TROGENIX LTD

HQ - Edinburgh

Summary

Trogenix is a biopharmaceutical company engaged in developing, manufacturing, and commercializing prescription medicines for central nervous system disorders and pain management.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 70 M

Avg. Deal Size£ 70 M

Market Context

Senior Management

Ken Macnamara
CEO